HSR26-207: Real-World Survival and Toxicity Outcomes of Tarlatamab in Relapsed or Refractory Small-Cell Lung Cancer: A Multicenter TriNetX Analysis Across Academic and Non-Academic Centers

View at publisher Summarise with VIRAT
Authors: Sai Sushrutha Mudupula Vemula, Safa Saadat Afridi, Niket Shah, Shreya Motkur, Ujwala Koduru, Rushi Shah, Faiza Kamal, Lucas Y Fernet, Suhail Sapkota, Borys W. Hrinczenko
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Lung Cancer Research Studies Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
Journal of the National Comprehensive Cancer Network
Volume
24
Issue
3.5
Publication date
27 March 2026
Language
EN